Challenged; withdrawn due to proactive dialogue
Resolution filed to recommend that the Board of Directors take the steps necessary to strengthen board oversight of prescription drug pricing risk by formalizing oversight responsibility, which could take the form of creating a new board committee or assigning responsibility to an existing committee, and by adding drug pricing risk expertise to the director qualifications skills matrix.
We and selected third parties use cookies or similar technologies for technical purposes and, with your consent, for other purposes. You can consent to the use of such technologies by using the “Accept” button, by closing this notice, by scrolling this page, by interacting with any link or button outside of this notice or by continuing to browse otherwise.